Drug Shortage Report for PHENYLEPHRINE HYDROCHLORIDE INJECTION USP

Last updated on 2024-03-23 History
Report ID 218216
Drug Identification Number 02504545
Brand name PHENYLEPHRINE HYDROCHLORIDE INJECTION USP
Common or Proper name PHENYLEPHRINE HYDROCHLORIDE INJECTION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) PHENYLEPHRINE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 25 VIALS X 1 ML
ATC code C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2024-01-31
Estimated end date 2024-03-29
Actual end date 2024-03-22
Shortage status Resolved
Updated date 2024-03-23
Company comments Limited inventory remains at McKesson.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2024-03-23 English Compare
v4 2024-03-22 French Compare
v3 2024-03-22 English Compare
v2 2024-02-02 French Compare
v1 2024-02-02 English Compare

Showing 1 to 5 of 5